A detailed history of Avantax Advisory Services, Inc. transactions in Bio Techne Corp stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 13,056 shares of TECH stock, worth $765,864. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,056
Previous 13,852 5.75%
Holding current value
$765,864
Previous $812,000 17.36%
% of portfolio
0.0%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 08, 2025

SELL
$46.66 - $58.38 $37,141 - $46,470
-796 Reduced 5.75%
13,056 $671,000
Q1 2025

May 06, 2025

BUY
$58.47 - $78.75 $188,916 - $254,441
3,231 Added 30.42%
13,852 $812,000
Q4 2024

Feb 07, 2025

SELL
$66.37 - $78.17 $128,359 - $151,180
-1,934 Reduced 15.4%
10,621 $765,000
Q3 2024

Nov 13, 2024

SELL
$70.96 - $82.35 $11,282 - $13,093
-159 Reduced 1.25%
12,555 $1 Million
Q2 2024

Aug 09, 2024

BUY
$62.12 - $84.15 $789,793 - $1.07 Million
12,714 New
12,714 $910,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.3B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Avantax Advisory Services, Inc. Portfolio

Follow Avantax Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Advisory Services, Inc. with notifications on news.